Scott Shuda Acquires 40,892 Shares of InfuSystem Holdings Inc (INFU) Stock

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Director Scott Shuda purchased 40,892 shares of the stock in a transaction on Wednesday, September 12th. The stock was bought at an average price of $3.30 per share, for a total transaction of $134,943.60. Following the completion of the transaction, the director now directly owns 3,504,666 shares of the company’s stock, valued at $11,565,397.80. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Scott Shuda also recently made the following trade(s):

  • On Friday, September 14th, Scott Shuda purchased 21,959 shares of InfuSystem stock. The stock was bought at an average price of $3.32 per share, for a total transaction of $72,903.88.
  • On Monday, September 10th, Scott Shuda purchased 15,651 shares of InfuSystem stock. The stock was bought at an average price of $3.30 per share, for a total transaction of $51,648.30.
  • On Wednesday, September 5th, Scott Shuda purchased 9,548 shares of InfuSystem stock. The stock was bought at an average price of $3.23 per share, for a total transaction of $30,840.04.
  • On Friday, September 7th, Scott Shuda purchased 23,406 shares of InfuSystem stock. The stock was bought at an average price of $3.24 per share, for a total transaction of $75,835.44.
  • On Thursday, August 30th, Scott Shuda purchased 72,479 shares of InfuSystem stock. The stock was bought at an average price of $3.16 per share, for a total transaction of $229,033.64.

Shares of INFU stock traded down $0.05 during trading hours on Friday, hitting $3.20. 4,104 shares of the company’s stock were exchanged, compared to its average volume of 36,368. InfuSystem Holdings Inc has a 52 week low of $1.90 and a 52 week high of $3.60.

InfuSystem (NYSEAMERICAN:INFU) last announced its earnings results on Tuesday, August 14th. The medical instruments supplier reported ($0.02) EPS for the quarter. The business had revenue of $16.42 million for the quarter. InfuSystem had a negative return on equity of 1.06% and a negative net margin of 0.73%.

Several hedge funds have recently made changes to their positions in INFU. Renaissance Technologies LLC lifted its stake in shares of InfuSystem by 76.4% during the second quarter. Renaissance Technologies LLC now owns 266,100 shares of the medical instruments supplier’s stock valued at $945,000 after acquiring an additional 115,236 shares during the period. Gabelli Funds LLC lifted its stake in shares of InfuSystem by 8.6% during the second quarter. Gabelli Funds LLC now owns 280,000 shares of the medical instruments supplier’s stock valued at $994,000 after acquiring an additional 22,188 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of InfuSystem by 30.2% during the second quarter. Dimensional Fund Advisors LP now owns 172,199 shares of the medical instruments supplier’s stock valued at $611,000 after acquiring an additional 39,957 shares during the period. FineMark National Bank & Trust lifted its stake in shares of InfuSystem by 12.0% during the second quarter. FineMark National Bank & Trust now owns 255,575 shares of the medical instruments supplier’s stock valued at $907,000 after acquiring an additional 27,341 shares during the period. Finally, Minerva Advisors LLC lifted its stake in shares of InfuSystem by 3.4% during the first quarter. Minerva Advisors LLC now owns 2,126,064 shares of the medical instruments supplier’s stock valued at $6,165,000 after acquiring an additional 70,000 shares during the period.

About InfuSystem

InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Further Reading: Marijuana Stocks Investing Considerations

Insider Buying and Selling by Quarter for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply